M. Pittet
Immunology · 2005–2022
A researcher in the Science corpus: 19 papers; trusts 18 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 430 citations into it; #905 of 2,160 by trust here, #234 by citations
- Oncology — 269 citations into it; #840 of 1,698 by trust here, #290 by citations
- Molecular Biology — 143 citations into it
- Cancer Research — 39 citations into it
- Epidemiology — 37 citations into it
- Biomedical Engineering — 32 citations into it; #4,888 of 10,734 by trust here, #3,931 by citations
- Physiology — 23 citations into it
- Biophysics — 17 citations into it; #564 of 1,196 by trust here, #524 by citations
Whom M. Pittet trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- N. Sharpless
- Binzhi Qian
- A. Mantovani
- J. Joyce
- N. Serbina
- Ralph Weissleder
- J. Pollard
- Rakesh K. Jain
- R. DePinho
- F. Swirski
Who trusts M. Pittet overall
Papers from M. Pittet's perspective
Ordered by how strongly the researchers M. Pittet trusts endorse each paper. Same corpus, a different order for every researcher.
- Development of monocytes, macrophages and dendritic cells (Science)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
- Immunity, Inflammation, and Cancer (Cell)
- Monocyte and macrophage heterogeneity (Nature reviews. Immunology)
- Gene expression profiles and transcriptional regulatory pathways underlying mouse tissue macrophage identity and diversity (Nature Immunology)
- A clonogenic common myeloid progenitor that gives rise to all myeloid lineages (Nature)
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (Nature Medicine)
- Immunogenic cell death in cancer therapy. (Annual Review of Immunology)
- PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
- Imaging in the era of molecular oncology (Nature)
Their papers
- The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide (2013) — 1,872 citations
- Imaging in the era of molecular oncology (2008) — 2,272 citations
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites (2009) — 2,240 citations
- Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. (2010) — 782 citations
- Therapeutic siRNA silencing in inflammatory monocytes (2011) — 835 citations
- Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species (2019) — 1,306 citations
- Clinical relevance of tumour-associated macrophages (2022) — 601 citations
- Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) — 5,098 citations
- Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 (2018) — 803 citations
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy (2018) — 704 citations
- Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy (2016) — 893 citations
- The role of myeloid cells in cancer therapies (2016) — 698 citations
- Imaging macrophages with nanoparticles. (2014) — 739 citations
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (2014) — 997 citations
- The spleen in local and systemic regulation of immunity (2013) — 983 citations
- Myocardial infarction accelerates atherosclerosis (2012) — 1,053 citations
- Origins of tumor-associated macrophages and neutrophils (2012) — 658 citations
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. (2007) — 1,304 citations
- Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo (2005) — 775 citations